Zhejiang Hisun Pharmaceutical Co Ltd (600267) — Cash Flow Reinvestment Rate
Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥102.69 Million (capex CN¥102.69 Million ) from operating cash flow of CN¥438.43 Million. Explore Zhejiang Hisun Pharmaceutical Co Ltd (600267) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Hisun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Zhejiang Hisun Pharmaceutical Co Ltd across 27 annual periods. Also explore Zhejiang Hisun Pharmaceutical Co Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Zhejiang Hisun Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600267 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | CN¥443.14 Million | CN¥2.03 Billion | CN¥376.40 Million | ▲ +76.9% |
| 2024 | 0.12x | CN¥260.70 Million | CN¥2.11 Billion | CN¥238.44 Million | ▼ -67.7% |
| 2023 | 0.38x | CN¥578.74 Million | CN¥1.52 Billion | CN¥240.04 Million | ▼ -29.0% |
| 2022 | 0.54x | CN¥1.11 Billion | CN¥2.07 Billion | CN¥530.62 Million | ▲ +29.1% |
| 2021 | 0.42x | CN¥722.31 Million | CN¥1.74 Billion | CN¥622.38 Million | ▼ -64.7% |
| 2020 | 1.18x | CN¥1.87 Billion | CN¥1.59 Billion | CN¥692.04 Million | ▼ -25.1% |
| 2019 | 1.57x | CN¥1.10 Billion | CN¥698.39 Million | CN¥1.08 Billion | ▲ +22.1% |
| 2018 | 1.29x | CN¥1.86 Billion | CN¥1.45 Billion | CN¥1.60 Billion | ▲ +3.5% |
| 2017 | 1.25x | CN¥1.54 Billion | CN¥1.24 Billion | CN¥1.46 Billion | ▼ -67.9% |
| 2016 | 3.88x | CN¥3.01 Billion | CN¥775.90 Million | CN¥1.77 Billion | ▲ +23.6% |
| 2015 | 3.14x | CN¥2.31 Billion | CN¥736.17 Million | CN¥1.93 Billion | ▼ -17.0% |
| 2014 | 3.78x | CN¥2.16 Billion | CN¥571.04 Million | CN¥2.16 Billion | ▼ -6.1% |
| 2013 | 4.02x | CN¥2.12 Billion | CN¥527.25 Million | CN¥2.12 Billion | ▼ -7.4% |
| 2012 | 4.34x | CN¥1.63 Billion | CN¥375.75 Million | CN¥1.63 Billion | ▲ +76.4% |
| 2011 | 2.46x | CN¥1.29 Billion | CN¥525.31 Million | CN¥1.29 Billion | ▲ +52.4% |
| 2010 | 1.62x | CN¥823.08 Million | CN¥509.18 Million | CN¥823.08 Million | ▼ -11.3% |
| 2009 | 1.82x | CN¥861.67 Million | CN¥472.85 Million | CN¥861.67 Million | ▼ -37.8% |
| 2008 | 2.93x | CN¥648.25 Million | CN¥221.28 Million | CN¥648.25 Million | ▲ +309.2% |
| 2007 | 0.72x | CN¥313.34 Million | CN¥437.72 Million | CN¥313.34 Million | ▼ -75.5% |
| 2006 | 2.92x | CN¥315.67 Million | CN¥108.03 Million | CN¥315.67 Million | ▲ +23.4% |
| 2005 | 2.37x | CN¥268.75 Million | CN¥113.53 Million | CN¥268.75 Million | ▲ +137.0% |
| 2004 | 1.00x | CN¥312.52 Million | CN¥312.93 Million | CN¥312.52 Million | ▲ +13.5% |
| 2003 | 0.88x | CN¥253.90 Million | CN¥288.45 Million | CN¥253.90 Million | ▼ -56.3% |
| 2002 | 2.01x | CN¥243.39 Million | CN¥120.82 Million | CN¥243.39 Million | ▼ -47.5% |
| 2001 | 3.84x | CN¥265.33 Million | CN¥69.14 Million | CN¥265.33 Million | ▲ +5.4% |
| 2000 | 3.64x | CN¥202.76 Million | CN¥55.70 Million | CN¥202.76 Million | ▼ -0.3% |
| 1999 | 3.65x | CN¥119.23 Million | CN¥32.64 Million | CN¥119.23 Million | — |